The 5th China Medicinal Biotech Forum

Feedback Form

Hosting Organization

China Medicinal Biotech Association

Operating Organization

Concurrent Conferences

Lungcancer

WCB2011

Media Partners

Event Report

On November 7-9, 2011, the 5th China Medicinal Biotech Forum was held successfully in Beijing, China.

As the keynote speakers, Dr. Erwin Neher, Nobel Prize Laureate in Physiology or Medicine 1991, Director of the Max Planck Institute for Biophysical Chemistry, Germany; Dr. Guo Wei Sang, Vice-Chairman of the Standing Committee of the National People's Congress, China; Dr. Qian Liu, Vice Minister of Ministry of Health of the People's Republic of China made excellent presentations and warmly discussed with the audiences at keynote forum.

Totally, there were more than 220 participants from more than 30 countries and areas have attended the CMBF-2011. Participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysis the development. The separate session covered the many aspects of medicinal biotech area.

CMBF-2011 greatly contributed to the promotion of new concepts for the development of efficient methodologies for medicinal biotech and its practical applications. The topics reflected and placed emphasis on aspects that are common to all areas of medicinal biotech.

Thanks for your support and attention to our conference and all the best for the participants to CMBF-2011!

Introduce

The 5^th China Medical Biotech Forum (CMBF-2011) will provide high level event for business leaders to know and enter Chinese market, deliver new products and advance understanding of the potential of new technologies, assisting professionals to network with other delegates and build up partnerships and raise your profile as a professional in the medicinal biotech field. CMBF-2011 will establish a unique platform for professionals meeting each other and discuss positive opportunities for international co-operation. We have invited the following two Keynote Speakers to attend:

Keynote Speakers

	Guo Wei Sang, Vice-Chairman of the Standing Committee of the National People's Congress, China	Title: Signals and Signalling Mechanisms in the Central Nervous System Dr. Erwin Neher, Nobel Prize Laureate in Physiology or Medicine 1991, Director of the Max Planck Institute for Biophysical Chemistry, Germany	Qian Liu, Vice Minister of Ministry of Health of the People's Republic of China



	Dr. Wolfgang Zimmermann, Professor, Universitat Leipzig, Germany	$C:\Documents and Settings\cathy\桌面\Dmitry Samarsky.jpg$	Dr. Dmitry Samarsky, VP, Technology Development, RXi Pharmaceuticals, USA		Dr. Theodosios Alexander, Professor and Chair, Queen Mary University of London, UK	$C:\Documents and Settings\Administrator\桌面\Bruce Whitney.jpg$	Dr. Bruce Whitney, AVP, Texas AM University,USA

	Dr. Gail K. Naughton, CEO/Chairman, Histogen Inc., USA	$C:\Documents and Settings\cathy\桌面\jiang.png$	Dr. Xin Jiang, Professor, University of Siegen, Germany	$C:\Documents and Settings\cathy\桌面\untitled.bmp$	Dr. Taolei Sun, Professor, Wuhan University of Technology, P. R. China	$C:\Documents and Settings\Administrator\桌面\Roche.jpg$	Dr. Anita Derks, Head, Pharma Technical Operations, Roche Products Pty Ltd, Australia

$C:\Documents and Settings\cathy\桌面\shaguna-seth.jpg$	Dr. Shaguna Seth, Vice President, Discovery Research and Pharmaceutical Development, Marina Biotech Inc., USA	$F:\各个会议\CMBF\专家\David Smith.jpg$	Dr. David Smith, Head, Cell Therapy, Lonza, Switzerland	$F:\各个会议\CMBF\专家\Jonathan Lewis.jpg$	Dr. Jonathan Lewis, CEO and CMO, Ziopharm Oncology, USA	$C:\Documents and Settings\Administrator\桌面\cmbf照片\Charles Brennan.jpg$	Dr. Charles Brennan, Professor, University of Manchester, UK

	Dr. Peter K. Watler, Chief Technology Officer, Principal Consultant, Hyde Engineering + Consulting, USA	$F:\各个会议\CMBF\专家\Robert Walton.JPG$	Dr. Robert Walton, Professor, University of London, UK		Dr. Jing Cheng, Professor, Tsinghua University School of Medicine, China	$C:\Documents and Settings\Administrator\桌面\无标题.bmp$	Dr. Kuo-Chen Chou, Chief Scientist & Professor, Gordon Life Science Institute, USA

	Dr. Dimiter S. Dimitrov, Senior Investigator, NCI, NIH, USA		Dr. Hua-Xin (Larry) Liao, Professor, Duke University Medical Center, USA		Dr. Lee-Jun C. Wong, Professor, Baylor College of Medicine, USA		Dr. John R. Adler, Professor, Stanford University Medical Center, USA

	Dr. Leopoldo Della Ciana, President, Cyanagen Srl, Italy		Dr. Michael Legg, President, HISA, Australia		Dr. Zhaohui (John) Cai, Biomedical Informatics Director, AstraZeneca, USA		Dr. Ferenc A. Jolesz, Professor, Harvard Medical School, USA

Program

Track 1: Biomedical Informatics	Track 8: Monoclonal Antibody
Track 2: Biochip Technologies	Track 9: Regenerative Medicine & Stem Cell
Track 3: Enzyme Engineering and Fermentation Engineering	Track 10: Biological Diagnostics
Track 4: Dietary Fibre	Track 11: Novel Technologies for Biotherapeutics
Track 5: Quality Control for Biotech Products	Track 12: Gene Engineering Drugs, Peptide Drugs and Vaccines
Track 6: Nanomedicine and Biomaterials	Track 13: Bone Tissue Bank
Track 7: Computer Assisted Surgery	Track 14: Clinical Application of Medical Biotechnology
Session for Young Scientist

Exhibition and Poster

Why Your Company Should Exhibit:

Position your products, services, and technologies in front of decision-makers
Maintain your competitive advantage within the scientific community
Meet with over 1000 of your prospects
Receive discounted conference registrations
Access to the post-event mailing list through a third party vendor
the congress will conduct strong branding and marketing campaigns to promote your participation

The 4^th China Medical Biotech Forum (CMBF-2009)

2009 the 4^th Medical Biotech Forum was successfully held in Dalian Municipal Party Committee Hotel, Dalian, China during Aug. 8-10, 2009. The 4th Medicinal Biotech Forum has provided carefully designed and high level event for business leaders to know and enter Chinese market, deliver new products and advance understanding of the potential of new technologies, helped the professionals to network with other delegates and built up partnerships and raise your profile as a professional in the medicinal biotech field. Meanwhile, it pushed forward the development of relevant scientific fields worldwide.More...